Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: heart disease

FDA Officials Speak Out: New Approvals & Safety Concerns Discussed

Thomas R. Collins  |  December 13, 2022

PHILADELPHIA—Officials from the U.S. Food & Drug Administration discussed recent drug approvals and drug safety issues at ACR Convergence in November in a session that captured the flurry of activity in the rheumatology sphere at the agency over the past year. Sabiha Khan, MD, clinical reviewer in the Division of Rheumatology and Transplant Medicine at…

Filed under:ACR ConvergenceDrug UpdatesLegislation & AdvocacyMeeting ReportsProfessional Topics Tagged with:ACR Convergence 2022drug approvalsFDA

Patients on Dialysis Taking Denosumab May Be at Risk of Severe Hypocalcemia

Michele B. Kaufman, PharmD, BCGP  |  December 12, 2022

The FDA is investigating the risk of severe hypocalcemia with serious outcomes, such as hospitalization and death, in patients on dialysis taking denosumab.

Filed under:Drug Updates Tagged with:denosumabdialysisDrug SafetyFDAhypocalcemiaRenal diseaseU.S. Food and Drug Administration (FDA)

Blood Is Thicker Than Water: Updates on the ACR/EULAR Antiphospholipid Syndrome Classification Criteria

Jason Liebowitz, MD, FACR  |  December 12, 2022

PHILADELPHIA—Ever since the seminal work of C. Lockard Conley, MD, in 1952 of the discovery of the lupus anticoagulant, antiphospholipid syndrome (APS) has been of great interest to rheumatologists, hematologists and many others. At ACR Convergence 2022, the session titled Draft ACR/EULAR Antiphospholipid Syndrome Classification Criteria sought to summarize the rigorous process that went into…

Filed under:ACR ConvergenceConditionsMeeting ReportsOther Rheumatic Conditions Tagged with:ACR Convergence 2022Antiphospholipid Antibody Syndrome (APS)

The 2022 ACR Masters

Patrice Fusillo  |  December 8, 2022

Recognition as an ACR Master is one of the highest honors the College bestows. The designation of Master is conferred on ACR members, age 65 or older by Oct. 1 of the year in which they are nominated, who have made outstanding contributions to the ACR and the field of rheumatology through scholarly achievement and/or…

Filed under:AwardsProfessional Topics Tagged with:Dr. Abraham “Avi” GedaliaDr. Alan KivitzDr. Andrew LasterDr. Anne DavidsonDr. Arvind ChopraDr. Asgar Ali KallaDr. Carlos D. RoseDr. Daniel AlbertDr. David A. CabralDr. Deh-Ming ChangDr. Ellen M. GravalleseDr. Frederick B. VivinoDr. H. Michael BelmontDr. Ken SchiklerDr. Larry W. MorelandDr. Leslie E. KahlDr. Linda BockenstedtDr. Maria C. CidDr. Max HamburgerDr. Munther A. KhamashtaDr. Nancy J. OlsenDr. Nina D. SchwartzDr. Richard BucalaDr. Robert A. S. RoubeyDr. Robert H. ShmerlingDr. Robert W. WarrenDr. Samina Hayat

The History of The Rheumatologist

Jason Liebowitz, MD, FACR  |  December 8, 2022

The Rheumatologist (TR) premiered in 2006, with its first full year of publication in 2007. In the 15 years since, it has sought to provide clinicians, researchers and healthcare providers with the most stimulating and educational content found in the field of rheumatology. The responsibility for achieving this mission has been borne by just three…

Filed under:From the CollegeProfessional Topics Tagged with:Physician EditorThe Rheumatologist

The Secret to Happiness

Philip Seo, MD, MHS  |  December 6, 2022

Are you happy? This may be a question born of the pandemic. Pre-pandemic, I used to quote William Osler, MD, who simultaneously founded the Department of Medicine at the Johns Hopkins Hospital and created the modern system of medical education. He opined: The practice of medicine will be very much as you make it—to one,…

Filed under:OpinionProfessional TopicsRheuminationsSpeak Out RheumWorkforce Tagged with:burnout

Patients Living with Chronic Illness

Thomas R. Collins  |  December 5, 2022

At ACR Convergence 2022, three women with rheumatic diseases discuss the profound life changes that the diseases wrought and ways they’ve found to cope.

Filed under:ACR ConvergenceMeeting ReportsPatient Perspective Tagged with:ACR Convergence 2022

Patients Fight Against Dark Days & Find Ways to Cope

Thomas R. Collins  |  December 2, 2022

PHILADELPHIA—Amy Gietzen started feeling the pain when she was 19. Her forearms, elbows, wrists and fingers were constantly swollen and sensitive. Six months later, she saw a doctor and was diagnosed with systemic diffuse scleroderma—a particularly hard-to-manage rheumatic disease with wide-ranging effects. Ms. Gietzen, who spoke at ACR Convergence 2022 and is a public speaker,…

Filed under:ACR ConvergenceConditionsMeeting ReportsPatient PerspectiveRheumatoid ArthritisSystemic Sclerosis Tagged with:ACR Convergence 2022self-managment

Lessons from Master Clinicians: An Interview with Dr. Eric Matteson

Jason Liebowitz, MD, FACR  |  November 10, 2022

Rheumatologists who are outstanding clinicians, provide consistently exceptional care to patients and serve as role models for colleagues and trainees are in the spotlight in our Lessons from a Master Clinician series. Here, we offer insights from clinicians who have achieved a level of distinction in the field of rheumatology. Eric L. Matteson, MD, MPH,…

Filed under:Profiles Tagged with:Dr. Eric MattesonLessons from Master CliniciansRole Models in Rheumatology

Speak Out Rheum: To Prescribe Is Humane (Unless You’re In Texas)

Raymond Scalettar, MD, DSc  |  November 7, 2022

You are a rheumatologist in Texas. You are very well trained. Your mentors included some of the leaders in rheumatology, and you are respected by your colleagues and your patients. You know the devastation of untreated rheumatoid arthritis and lupus. A young woman with recent onset of systemic lupus erythematosus is your new patient. You…

Filed under:EthicsLegal UpdatesOpinionProfessional TopicsSpeak Out Rheum Tagged with:abortionMethotrexatepregnancySpeak Out Rheumatology

  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 81
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences